Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nasdaq Biotechnology Ishares ETF
(NQ:
IBB
)
144.77
-0.83 (-0.57%)
Official Closing Price
Updated: 4:15 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nasdaq Biotechnology Ishares ETF
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
April 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Best Biotech Stocks & ETFs for mRNA, Gene Editing
April 29, 2021
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
Via
Talk Markets
Solar and Steel Shining, Biotech Bounces, and Miners Moving
April 27, 2021
Given it had traded in oversold territory for most of the past two months, TAN’s recent rally has not even been enough to bring the ETF back above its 50-DMA.
Via
Talk Markets
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
Are The Major Indices Poised For A Powerful Move Up Monday?
April 25, 2021
The Russell 2000, Nasdaq 100, Dow Jones and the S&P 500 all have the potential to make large moves Monday, if they clear their resistance levels together.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
BlackRock Announces Product Updates to Two iShares ETFs
April 22, 2021
From
BlackRock, Inc.
Via
Business Wire
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
3 Buy-Rated Biotech Stocks Under $10
April 20, 2021
The biotech industry has been at the center of investor attention over the past year thanks to the COVID-19 pandemic and an accompanying global race for a vaccine.
Via
Talk Markets
Exposures
COVID-19
Why We Bought Gold Before Thursdays Gap Up
April 18, 2021
Governments and central banks around the world have borrowed huge amounts of money to revive the economy. Without any clear plan to dig the U.S out of debt, there is rising worry that the U.S dollar...
Via
Talk Markets
Topics
Economy
Exposures
Economy
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
April 17, 2021
Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American...
Via
Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
1 Cancer Stock to Buy and Hold for the Next Decade
April 17, 2021
Blueprint Medicines is setting itself up to become the leader in precision oncology.
Via
The Motley Fool
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
April 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
April 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...
Via
Benzinga
Reddit Stocks That Are Waking Up In April 2021
April 15, 2021
Reddit has become synonymous with retail traders. The markets have seen much lighter volume this month, overall. Several stocks have begun trending among retail (Reddit) traders
Via
Talk Markets
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
April 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
April 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...
Via
Benzinga
Why the Nasdaq 100 (QQQ) Needs to Hold Near Highs
April 14, 2021
Wednesday was not only a big day for the crypto space, but also for the Russell 2000 (IWM) which initially had a large rally but eked out a close just over its 50-day moving average at $222.84.
Via
Talk Markets
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
How Does Coinbase Affect the Tech Sector?
April 13, 2021
COIN could give another boost to the tech sector as it will be one of the first publicly traded companies that helps people buy cryptocurrencies.
Via
Talk Markets
How To Play Lagging Healthcare Stocks
April 13, 2021
The Healthcare Select SPDR Fund (XLV) gives you the most diversified play in healthcare returning 11.4% in ’20 and 4% YTD.
Via
Talk Markets
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
April 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (...
Via
Benzinga
Exposures
Product Safety
How To Navigate The Market With These 3 Symbols
April 11, 2021
Last week’s focus was the Russel 2000, Transportation, and Semiconductors. The Russell 2000 has shown us general market direction and sentiment as it contains 2000 small cap U.S companies.
Via
Talk Markets
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
April 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
April 10, 2021
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
April 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc...
Via
Benzinga
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
April 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
Is Gilead Sciences Stock a Buy?
April 08, 2021
This is one contrarian investment you don't want to miss out on.
Via
The Motley Fool
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.